But Are Clinicians Missing the First Step?
Search interest in psychedelic-assisted therapy training has exploded. Clinicians across psychiatry, psychology, nursing, and integrative medicine are looking for answers about ketamine, psilocybin, MDMA-assisted therapy, and what these emerging treatments may mean for patient care.
The excitement is understandable.
For many patients with depression, trauma, anxiety, and treatment-resistant conditions, psychedelic therapies represent a new frontier—one that offers real promise. Clinicians are seeking to grow their expertise and training in psychedelic-assisted therapy, largely based on this demand.
But amid the headlines, hype, and rapid demand for training, an important clinical question is often overlooked:
Are we skipping the foundations of mental health treatment in the rush toward psychedelics?
At Psychiatry Redefined, we believe psychedelic medicine may become an important part of the future of psychiatry. But we also believe it is rarely the best first step.
The Media Narrative of Psychedelic Therapy vs. Clinical Reality
Popular media often presents psychedelics as breakthrough solutions capable of transforming mental health in a single experience. The reality is more nuanced.
Many clinicians are now seeing patients who have pursued ketamine or other psychedelic treatments with mixed results. Some report temporary relief. Some describe life-changing experiences. Others improve briefly, then relapse. And many never addressed the underlying biological imbalances contributing to their symptoms in the first place.
When root causes remain untreated, even promising therapies may under-perform.
What Often Gets Missed First in Treating Mental Health: Nutritional and Biological Foundations
Before considering psychedelic interventions, clinicians should ask:
- Does this patient have iron deficiency, B12 deficiency, or low folate?
- Are vitamin D levels suboptimal?
- Is there insulin resistance or blood sugar instability?
- Are thyroid or hormonal issues contributing to symptoms?
- Is chronic inflammation present?
- Are gut health issues affecting neurotransmitter balance?
- Is sleep dysfunction driving mood and anxiety symptoms?
- Are medication side effects complicating the picture?
These are not fringe ideas. They are core aspects of evidence-based, whole-person psychiatry. Yet many patients move toward advanced interventions before these basics are fully explored.
Psychedelics as a Second Step— in Mental Health Treatment, Not a Shortcut
Dr. James Greenblatt has long recognized the promise of psychedelic therapies. For select patients, in the right setting, with proper screening and integration, they may be highly valuable.
But positioning psychedelics as a primary treatment pathway for broad populations is premature. A more responsible model is:
- Comprehensive assessment
- Optimize neurobiology and physical health
- Correct nutritional deficiencies
- Address inflammation, metabolism, hormones, sleep, and lifestyle
- Use conventional treatments thoughtfully
- Then consider psychedelic therapies when clinically appropriate
This approach is not anti-psychedelic. It is pro-personalized patient care which can include psychedelic therapy treatment.
Why Functional Psychiatry Improves Outcomes
When clinicians stabilize the biological terrain first, they often see:
- Better resilience before treatment
- Improved response to therapy
- Reduced symptom burden
- Better emotional regulation
- More durable outcomes
- Clearer understanding of what interventions are truly helping
Sometimes symptoms improve so significantly through foundational treatment that higher-risk or higher-cost interventions are no longer necessary.
That is precision medicine.
Why Clinicians Need Better Training—Not Just Trend Training
The rise in searches for psychedelic-assisted therapy training signals something deeper: Clinicians know traditional symptom-management models are incomplete. They are seeking broader tools.
We agree. But psychedelic education alone is not enough.
Clinicians need training that helps them understand the complete picture of a patient—biological, nutritional, psychological, metabolic, and environmental factors that shape mental health.
That is why one of the nine core subject areas in the Psychiatry Redefined Fellowship includes psychedelics—within the context of a far more comprehensive model.
A Smarter Way Forward in Psychiatry
The future of psychiatry will likely include psychedelics. But it should also include:
- Biomarkers
- Personalized nutrition
- Functional lab testing
- Metabolic psychiatry
- Gut-brain science
- Hormonal balance
- Thoughtful medication use
- Trauma-informed care
- Lifestyle medicine
In other words: a model that looks deeper before reaching further.
For Clinicians Ready to Learn the Full Model
If you are searching for psychedelic-assisted therapy training, you are likely searching for something more than a trend. You are searching for better ways to help patients heal.
We invite you to start with a stronger foundation.
The Psychiatry Redefined Fellowship trains clinicians in the most comprehensive evidence-based model of functional, integrative, and personalized mental healthcare available today—including when and where psychedelics may fit.
Because the best outcomes rarely come from one tool.
They come from understanding the whole patient.
